a public good project by the
Synthesis
Company
of California

© 2026

S. Aubrey Stoch | doi.page

0 works0 citations0 h-index

S. Aubrey Stoch

Merck & Co., Inc., Rahway, NJ, USA (United States)(US)

Publications by Year

Research Areas

HIV/AIDS drug development and treatment, Bone health and treatments, Bone health and osteoporosis research, Pharmacogenetics and Drug Metabolism, Bone Metabolism and Diseases

Most-Cited Works

→ Bone Loss in Men with Prostate Cancer Treated with Gonadotropin-Releasing Hormone Agonists1(2001)186 cited
→ Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide1Bclinical probe than rosuvastatin(2014)163 cited
→ Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies(2009)156 cited
→ Effect of L-000845704, an αVβ3 Integrin Antagonist, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women(2005)136 cited
→ Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor(2023)124 cited
→ Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial(2009)98 cited

→ Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial(2020)

91 cited

→ Best practices for the use of itraconazole as a replacement for ketoconazole in drug–drug interaction studies(2015)85 cited

→ Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil(2019)83 cited

→ Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics – results from single oral dose studies in healthy volunteers(2012)77 cited